🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to conduct a pilot study using biologic agen...
Status
Completed
Location
Boston Childrens Hospital
Start Date
2008-10
Trial ID
NCT00891527
Treatments Being Tested
IMPRESS-Norway is a prospective, non-randomized clinical trial evaluating e...
Status
Recruiting
Location
Sykehuset Ålesund
Start Date
2021-04-01
Trial ID
NCT04817956
Treatments Being Tested
This is a Phase I, dose finding, multicentre study evaluating the maximal t...
Status
Terminated
Location
Novarts Investigative Site
Start Date
2007-10
Trial ID
NCT01271166
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of tumor cells by blocking...
Status
Completed
Location
Seattle Cancer Care Alliance
Start Date
2006-11
Trial ID
NCT00425646
Treatments Being Tested
Assessment of safety and toxicity, definition of the dose limiting toxicity...
Status
Completed
Location
Medical Clinic for Haematology and Oncology
Start Date
2008-04
Trial ID
NCT00784446
Treatments Being Tested
Phase II trial to study the effectiveness of combining imatinib mesylate wi...
Status
Completed
Location
Abramson Cancer Center of The University of Pennsylvania
Start Date
2003-10
Trial ID
NCT00074308
Treatments Being Tested
This randomized phase III trial studies imatinib mesylate and bevacizumab t...
Status
Terminated
Location
Alta Bates Summit Medical Center-Herrick Campus
Start Date
2008-04
Trial ID
NCT00324987
Treatments Being Tested
This phase I/II trial will evaluate the bevacizumab/erlotinib combination w...
Status
Completed
Location
Multiple Locations
Start Date
2004-06
Trial ID
NCT00193258
Treatments Being Tested
This phase Ib trial determines if samples from a patient's cancer can be te...
Status
Terminated
Location
OHSU Knight Cancer Institute
Start Date
2020-04-01
Trial ID
NCT03878524
Treatments Being Tested
RATIONALE: Imatinib may stop the growth of tumor cells by blocking some of ...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2006-08
Trial ID
NCT00390156
Treatments Being Tested